ADC Therapeutics SA (ADCT) vs Journey Medical Corporation (DERM)

ADC Therapeutics SA and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $121.4M — 1.7× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 3.03%. Journey Medical Corporation has the higher net margin (−8.95% vs −121.8%) and the lower return on invested capital (−5.89% vs 0.00%). Across the 17 metrics below, Journey Medical Corporation leads on 11 and ADC Therapeutics SA on 6.

Valuation

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 1.73 2.08
P/B n/m 3.68 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 67.73 12.22
EV/Sales 1.95 1.73 2.87
Earnings yield (39.76%) (5.12%) (15.94%)
Free cash flow yield (39.53%) (19.02%) 0.00%

Profitability

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 65.45% 53.51%
Operating margin (125.08%) (4.41%) 0.00%
Net margin (121.77%) (8.95%) (2.45%)
Free cash flow margin (127.72%) (10.99%) 0.00%
Return on equity 45.35% (23.77%) (0.80%)
Return on assets (32.25%) (6.80%) (1.67%)
Return on invested capital 0.00% (5.89%) 0.00%

Growth

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% 20.89% 5.22%
EPS growth (last fiscal year) 30.86% 34.72% 42.91%
Revenue growth, 5-year CAGR 103.35% 6.79% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.79 0.04
Current ratio 3.03 1.59 2.41
Net debt to EBITDA 1.22 (0.35) 1.01

Dividend

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT DERM Drug Manufacturers Specialty & Generic median
Market cap 209.38m 121.36m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack